Trial Design Solutions
-
Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility
6/29/2021
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
Simplify EDC Workflow With Integrated Randomization
1/30/2026
By unifying randomization and data collection into a single solution with a single sign-on, this service eliminates the need for complex data reconciliation between separate platforms.
-
Patient Recruitment And Site Selection
12/20/2022
Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
-
Your Top Partner For Ophthalmic Drug Development
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Unify Workflows And Accelerate Execution From Protocol To Submission
2/2/2026
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
-
Citeline Connect: The All-In-One Clinical Trial Recruitment Platform
7/18/2022
Citeline Connect is an end-to-end trial education, enrollment and recruiting platform that accelerates study startup, drives engagement, and enables community and communication surrounding clinical trials.
-
De-Risk Randomization With The Endpoint Biostatistical Approach
12/5/2025
With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
-
Cardiovascular, Renal And Metabolic Clinical Development
1/14/2026
CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.
-
Selecting The Right Pain Model For Early Phase Analgesic Trials
1/26/2023
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
Rare Disease Center Of Excellence Overcomes Unique Obstacles
7/14/2022
Biorasi’s Beeline platform provides clinical teams with unique, real-time transparency for quick responses to rare and urgent disease trial challenges.